Curi Bio raises $10M Series A to advance Mantarry stem cell drug-discovery platform
Seattle startup Curi Bio raised $10 million in Series A to advance its Mantarry stem cell-focused drug discovery platform and expand the business.
More: Curi Bio, GeekWire
- Curi Bio / Arianna Kieser: Curi Bio closes $10M oversubscribed Series A led by Dynamk Capital with new investors UTC Investment and DS Asset Management
-
GeekWire / Charlotte Schubert: Curi Bio raises $10M to advance iPSC-based 3D tissue drug-discovery platforms including Mantarray